{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:21:38Z","timestamp":1789154498845,"version":"build-2803163510"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,31]]},"DOI":"10.7759\/cureus.78295","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T18:11:11Z","timestamp":1738347071000},"source":"Crossref","is-referenced-by-count":1,"title":["Dobutamine-Induced Myoclonus in a Patient With Acute Decompensated Heart Failure and Acute Kidney Injury: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Saeed K","family":"Alzghari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus D","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob C","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Dobutamine","author":"Ashkar H","year":"2025","unstructured":"Ashkar H, Adnan G, Patel P, Makaryus A. Dobutamine. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2025."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-016-8357-z","article-title":"The clinical heterogeneity of drug-induced myoclonus: an illustrated review","volume":"264","author":"Janssen S","year":"2017","unstructured":"Janssen S, Bloem BR, van de Warrenburg BP. The clinical heterogeneity of drug-induced myoclonus: an illustrated review. J Neurol. 2017, 264:1559-66. 10.1007\/s00415-016-8357-z","journal-title":"J Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7326\/aimcc.2023.0876","article-title":"Dobutamine-induced myoclonus: acute myoclonus with continuous dobutamine and chronic kidney disease","volume":"3","author":"Sunnaa M","year":"2024","unstructured":"Sunnaa M, Kerolos M, Satterfield M, Shakoor R, Koirala S, Snell J. Dobutamine-induced myoclonus: acute myoclonus with continuous dobutamine and chronic kidney disease. AIM Clinical Cases. 2024, 3:e230876. 10.7326\/aimcc.2023.0876","journal-title":"AIM Clinical Cases"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccas.2024.102255","article-title":"Dobutamine-induced myoclonus in a patient with advanced heart failure and chronic kidney disease","volume":"29","author":"Lee AY","year":"2024","unstructured":"Lee AY, Barforoshi S, Singh A, Shrestha R, Ha J, Kittleson M. Dobutamine-induced myoclonus in a patient with advanced heart failure and chronic kidney disease. JACC Case Rep. 2024, 29:102255. 10.1016\/j.jaccas.2024.102255","journal-title":"JACC Case Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2022.100591","article-title":"Dobutamine-induced myoclonus in a peritoneal dialysis patient: case report","volume":"5","author":"Noel E","year":"2023","unstructured":"Noel E, Fayoda B, Rabbani R, Benjamin YS, Lee J, Gillespie A. Dobutamine-induced myoclonus in a peritoneal dialysis patient: case report. Kidney Med. 2023, 5:100591. 10.1016\/j.xkme.2022.100591","journal-title":"Kidney Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.96.15_supplement.5125","article-title":"Drug-induced myoclonus in a patient on continuous dobutamine infusion (5125)","volume":"96","author":"Zamora M","year":"2021","unstructured":"Zamora M, Shpiner D. Drug-induced myoclonus in a patient on continuous dobutamine infusion (5125). Neurology. 2021, 96:5125. 10.1212\/WNL.96.15_supplement.5125","journal-title":"Neurology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp060326","article-title":"Myoclonus associated with continuous dobutamine infusion in a patient with end-stage renal disease","volume":"64","author":"Boord A","year":"2007","unstructured":"Boord A, Benson B. Myoclonus associated with continuous dobutamine infusion in a patient with end-stage renal disease. Am J Health Syst Pharm. 2007, 64:2241-3. 10.2146\/ajhp060326","journal-title":"Am J Health Syst Pharm"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh132","article-title":"Dobutamine-induced myoclonia in severe renal failure","volume":"19","author":"Wierre L","year":"2004","unstructured":"Wierre L, Decaudin B, Barsumau J, Vairon MX, Horrent S, Odou P, Azar R. Dobutamine-induced myoclonia in severe renal failure. Nephrol Dial Transplant. 2004, 19:1336-7. 10.1093\/ndt\/gfh132","journal-title":"Nephrol Dial Transplant"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3109\/02770909009073289","article-title":"Skeletal muscle tremor and the influence of adrenergic drugs","volume":"27","author":"Ahrens RC","year":"1990","unstructured":"Ahrens RC. Skeletal muscle tremor and the influence of adrenergic drugs. J Asthma. 1990, 27:11-20. 10.3109\/02770909009073289","journal-title":"J Asthma"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-45. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-013-0216-3","article-title":"Treatment of myoclonus","volume":"11","author":"Caviness JN","year":"2014","unstructured":"Caviness JN. Treatment of myoclonus. Neurotherapeutics. 2014, 11:188-200. 10.1007\/s13311-013-0216-3","journal-title":"Neurotherapeutics"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1980.tb01797.x","article-title":"Methyl conjugation in uraemia: catechol-O-methyltransferase","volume":"10","author":"Pazmi\u00f1o PA","year":"1980","unstructured":"Pazmi\u00f1o PA, Weinshilboum RM. Methyl conjugation in uraemia: catechol-O-methyltransferase. Br J Clin Pharmacol. 1980, 10:509-18. 10.1111\/j.1365-2125.1980.tb01797.x","journal-title":"Br J Clin Pharmacol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.13099","article-title":"Reversible facial myoclonus in uremia","volume":"8","author":"Rani P","year":"2021","unstructured":"Rani P, Sharma R, Tater P. Reversible facial myoclonus in uremia. Mov Disord Clin Pract. 2021, 8:133-4. 10.1002\/mdc3.13099","journal-title":"Mov Disord Clin Pract"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/336423-dobutamine-induced-myoclonus-in-a-patient-with-acute-decompensated-heart-failure-and-acute-kidney-injury-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T18:11:12Z","timestamp":1738347072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/336423-dobutamine-induced-myoclonus-in-a-patient-with-acute-decompensated-heart-failure-and-acute-kidney-injury-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.78295","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,31]]}}}